RACGP criticises push to make asthma preventer OTC

Press/Media: Expert Comment

Description

The TGA will consider the unnamed application for inhaled budesonide later this month. A bid to the drugs watchdog to make an inhaled corticosteroid available OTC will not stop patients with asthma overusing salbutamol and could result in a two-tier system in rural areas, the RACGP warns.

Subject

Asthma

General Practice

Medication safety

Period6 Jun 2022

Media contributions

1

Media contributions

  • TitleRACGP criticises push to make asthma preventer OTC
    Degree of recognitionNational
    Media name/outletAusDoc
    Media typeWeb
    Country/TerritoryAustralia
    Date6/06/22
    DescriptionA bid to the drugs watchdog to make an inhaled corticosteroid available OTC will not stop patients with asthma overusing salbutamol and could result in a two-tier system in rural areas, the RACGP warns.
    Producer/AuthorSiobhan Calafiore
    PersonsMark Morgan